641636-83-1Relevant academic research and scientific papers
COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON LIKE PEPTIDE (GLP)-1 COMPOUND OR AN MELANOCORTIN 4 RECEPTOR (MC4) AGONIST PEPTIDE
-
Page/Page column 17, (2008/06/13)
The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.
A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units
Dai, Yujia,Guo, Yan,Curtin, Michael L.,Li, Junling,Pease, Lori J.,Guo, Jun,Marcotte, Patrick A.,Glaser, Keith B.,Davidsen, Steven K.,Michaelides, Michael R.
, p. 3817 - 3820 (2007/10/03)
A series of structurally novel HDAC inhibitors, in which a hetero aromatic ring connects the spacer with the hydrophobic group, has been designed and synthesized. These new inhibitors are very potent in in vitro enzymatic assays and display antiproliferation activity against two human cancer cell lines.
